Private company

Legato Merger Corp. III

Blank check company in the Cayman Islands1

In its 2026 annual report the company says: “We are a blank check company incorporated in the Cayman Islands on November 6, 2023, as an exempted company, formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more target businesses or entities.”3 It is headquartered in New York, New York.1

Last updated Oct 20, 2026.

Overview

  • IndustryBlank Checks1
  • HeadquartersNew York, New York1
  • Incorporated inCayman Islands2
  • Business address777 Third Avenue, 37Th Floor, New York, Ny 100172
  • Filer category, Emerging growth company2

We are a blank check company incorporated in the Cayman Islands on November 6, 2023, as an exempted company, formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more target businesses or entities. Our efforts to identify a prospective target business will not be limited to a particular industry or geographic region although we are currently focusing on target businesses in the infrastructure, E&C, industrial and renewables industries.3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income4-$1.0M in 2025+55% since 2024
-$1.5M-$1.0M-$500.0K02024: -$670.4K-$670.4K20242025: -$1.0M-$1.0M2025+55%
Net income4$7.9M in 2025−4% since 2024
0$2.5M$5.0M$7.5M$10.0M2024: $8.2M$8.2M20242025: $7.9M$7.9M2025−4%
Fiscal year2023202420252026
Operating income-$670.4K4-$1.0M4
Net income$8.2M4$7.9M4

Compare Legato Merger Corp. III with another company

Corporate structure

Legato Merger Corp. III sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Legato Merger Corp. III

  • First Trust Capital Management L.P. Filed SCHEDULE 13G/A on Legato Merger Corp. III, latest Aug 14, 2026 (3 filings since Nov 14, 2024)
  • Wealthspring Capital LLC Filed SCHEDULE 13G/A on Legato Merger Corp. III, latest Jul 9, 2026 (2 filings since Nov 14, 2024)
  • Karpus Management, Inc. Filed SCHEDULE 13G/A on Legato Merger Corp. III, latest Jun 5, 2026 (5 filings since Aug 8, 2024)
  • Barclays Filed SCHEDULE 13G/A on Legato Merger Corp. III, latest Feb 11, 2026 (3 filings since Feb 7, 2025)
  • AQR CAPITAL MANAGEMENT LLC Filed SC 13G on Legato Merger Corp. III, latest Nov 14, 2024
  • SPRING CREEK CAPITAL LLC Filed SC 13G/A on Legato Merger Corp. III, latest Aug 9, 2024 (2 filings since Feb 9, 2024)
  • Eric Rosenfeld Filed SC 13D on Legato Merger Corp. III, latest Feb 15, 2024
  • Legato Merger Corp. III New York, New York

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Legato Merger Corp. III reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$839.8K4 Nov 30, 2025$1.6M4 Nov 30, 2024−48.3%

Properties, in its own words

We currently maintain our principal executive offices at 777 Third Avenue, 37th Floor, New York, New York 10017. The cost for this space is included in the $20,000 per-month fee Crescendo Advisors II, LLC, an entity controlled by Mr. Rosenfeld, charges us for general and administrative services pursuant to a letter agreement between us and Crescendo Advisors II, LLC. We believe, based on rents and fees for similar services, that the fee charged by Crescendo Advisors II, LLC is at least as favorable as we could have obtained from an unaffiliated person. We consider our current office space, combined with the other office space otherwise available to our executive officers, adequate for our current operations.

Item 2 of the 10-K filed Feb 10, 2026.3

Leadership

Who has led Legato Merger Corp. III, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Gregory R. Monahan2024

Chief financial officer

  1. Adam H. Jaffe2024
2025
Board members and other officers (7)

Timeline

  1. Jun 10, 20268-K Entered a material agreement; Ended a material agreement; Completed an acquisition or sale17
  2. Jun 5, 20268-K Shareholder vote18
  3. May 6, 20268-K New debt or obligation; Bylaws or fiscal year changed; Shareholder vote19
  4. Feb 26, 20268-K Entered a material agreement; Regulation FD disclosure20
  5. Nov 12, 20258-K Entered a material agreement; Regulation FD disclosure21
  6. Feb 14, 20248-K Unregistered sale of shares; Other events22
  7. Feb 6, 20248-K Entered a material agreement23
  8. Feb 5, 2024New chief executive Gregory R. Monahan becomes CEO10

Filings

70 filings to the SEC since October 2021: 3 annual reports, 7 quarterly reports, 7 major events, 11 insider forms, 17 large holders, 25 other. The latest 20:

  1. Aug 14, 2026SCHEDULE 13G/A EDGAR
  2. Jul 9, 2026SCHEDULE 13G/A EDGAR
  3. Jun 23, 202615-12G EDGAR
  4. Jun 10, 20268-K EDGAR
  5. Jun 5, 20268-K EDGAR
  6. Jun 5, 2026SCHEDULE 13G/A EDGAR
  7. May 15, 2026DEFM14A EDGAR
  8. May 6, 2026425 EDGAR
  9. May 6, 20268-K EDGAR
  10. Apr 28, 2026UPLOAD EDGAR
  11. Apr 14, 202610-Q EDGAR
  12. Apr 13, 2026CORRESP EDGAR
  13. Apr 13, 202610-K/A EDGAR
  14. Apr 10, 2026UPLOAD EDGAR
  15. Apr 7, 2026DEF 14A EDGAR
  16. Apr 7, 2026SCHEDULE 13G/A EDGAR
  17. Mar 27, 2026PRE 14A EDGAR
  18. Feb 26, 2026425 EDGAR
  19. Feb 26, 20268-K EDGAR
  20. Feb 13, 2026SCHEDULE 13G/A EDGAR

The 70 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

3 open-market trades by officers, directors and large owners since October 2021: 1 buys and 2 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Apr 1, 2024Pratt BrianDirectorSale40,000Form 4
Mar 1, 2024ROSENFELD ERICChief SPAC OfficerBuy1,150,000Form 4
Feb 27, 2024ROSENFELD ERICChief SPAC OfficerSale1,150,000Form 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Legato Merger Corp. III is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARLegato Merger Corp. III1
  • CIK0002002038
  • Employer ID (EIN)98-17611483
  • Filer statusNon-accelerated filer an emerging growth company; a smaller reporting company; a shell company3
  • Incorporated inCayman Islands3
  • Fiscal year endsNovember 301
  • Industry code (SIC)6770 Blank Checks1
  • SEC reviewing officeOffice of Real Estate & Construction, Division of Corporation Finance1
  • Business address777 Third Avenue, 37Th Floor, New York, NY 100171
  • Phone(212) 319-76761
  • Shares outstanding25,799,375 as of Apr 14, 20267
  • Public float$213.7M as of May 31, 20253
  • AuditorWithumSmith+Brown, PC, New York PCAOB ID 1003
  • On EDGAR sinceDec 7, 20231
  • Filings101 in all: 425 (31), SCHEDULE 13G/A (9), 10-Q (7), 3 (7), 8-K (7), CORRESP (5), SC 13G (5), S-1/A (4)1
    All 26 form types

    UPLOAD (4), 4 (3), 10-K (2), SC 13G/A (2), SCHEDULE 13G (2), 10-K/A (1), 15-12G (1), 25-NSE (1), 4/A (1), 424B4 (1), 8-A12B (1), CERT (1), DEF 14A (1), DEFM14A (1), EFFECT (1), PRE 14A (1), S-1 (1), SC 13D (1)

  • Latest filingsAnnual report (10-K) Feb 10, 2026
    Quarterly report (10-Q) Apr 14, 2026
    Proxy statement (DEF 14A) Apr 7, 2026
    Latest 8-K (8-K) Jun 10, 2026

Securities registered for trading

ClassSymbolExchange
Units, each consisting of one ordinary share, $0.0001 par value, and one-half of one redeemable warrantLEGT UNYSE American
Ordinary Shares, par value $0.0001 per shareLEGTNYSE American
Redeemable warrants, exercisable for ordinary shares at an exercise price of $11.50 per shareLEGT WSNYSE American

From the cover page of the 10-K filed Feb 10, 2026 (Section 12(b) of the Exchange Act).3

Risk factors and legal proceedings

The risks Legato Merger Corp. III names in Item 1A of its 10-K filed Feb 10, 2026: 66 risks under these headings, as written.3

  • Risks Relating to Searching for and Consummating a Business Combination
  • We are a Cayman Islands exempted company with no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve our business objective.
  • If we are unable to consummate a business combination, our public shareholders may be forced to wait more than 27 months from the date of the IPO before receiving distributions from the trust account.
  • The requirement that we complete an initial business combination by June 8, 2026 may give potential target businesses leverage over us in negotiating a business combination.
  • Our public shareholders may not be afforded an opportunity to vote on our proposed business combination.
  • Since we have not yet selected a particular industry or target business with which to complete a business combination, we are unable to currently ascertain the merits or risks of the industry or business in which we may ultimately operate.
  • The ability of our shareholders to exercise their conversion rights or sell their shares to us in a tender offer may not allow us to effectuate the most desirable business combination or optimize our capital structure.
  • In connection with any vote to approve a business combination, we will offer each public shareholder the right to seek conversion of his, her or its shares regardless of how the shareholder votes on the business combination.
  • We do not have a specified maximum conversion threshold. The absence of such a conversion threshold may make it easier for us to consummate a business combination even where a substantial number of public shareholders seek to convert their shares to cash in connection with the vote on the business combination.
  • In connection with any general meeting called to approve a proposed initial business combination, we may require shareholders who wish to convert their shares in connection with a proposed business combination to comply with specific requirements for conversion that may make it more difficult for them to exercise their conversion rights prior to the deadline for exercising their rights.
  • If, in connection with any general meeting called to approve a proposed business combination, we require public shareholders who wish to convert their shares to comply with specific requirements for conversion, such converting shareholders may be unable to sell their securities when they wish to in the event that the proposed business combination is not approved.
  • Because of our structure, other companies may have a competitive advantage and we may not be able to consummate an attractive business combination.
The other 55 risks
  • Because we must furnish our shareholders with target business financial statements prepared in accordance with U.S. generally accepted accounting principles or international financial reporting standards, we will not be able to complete a business combination with prospective target businesses unless their financial statements are prepared in accordance with U.S. generally accepted accounting principles or international financial reporting standards.
  • A provision of our warrant agreement may make it more difficult for us to consummate an initial business combination.
  • We may issue shares or debt securities to complete a business combination, which would reduce the equity interest of our shareholders and likely cause a change in control of our company.
  • We may be unable to obtain additional financing, if required, to complete a business combination or to fund the operations and growth of the target business, which could compel us to restructure or abandon a particular business combination.
  • If the net proceeds of our IPO not being held in trust are insufficient to allow us to operate until at least June 8, 2026, we may be unable to complete a business combination.
  • We may not obtain a fairness opinion with respect to the target business that we seek to acquire and therefore you may be relying solely on the judgment of our board of directors in approving a proposed business combination.
  • Resources could be spent researching acquisitions that are not consummated, which could materially adversely affect subsequent attempts to locate and acquire or merge with another business.
  • We may only be able to complete one business combination with the proceeds of our IPO, which will cause us to be solely dependent on a single business which may have a limited number of products or services.
  • Our search for an initial business combination, and any target business with which we ultimately consummate an initial business combination, may be materially adversely affected by new outbreaks, or continuation of any existing outbreaks, of any infectious disease (such as COVID-19) and other events, and the status of debt and equity markets.
  • As the number of special purpose acquisition companies evaluating targets increases, attractive targets may become scarcer and there may be more competition for attractive targets. This could increase the cost of our initial business combination and could even result in our inability to find a target or to consummate an initial business combination.
  • Changes in the market for directors and officers liability insurance could make it more difficult and more expensive for us to negotiate and complete an initial business combination.
  • If our initial business combination involves a company organized under the laws of a state of the United States, it is possible a 1% U.S. federal excise tax will be imposed on us in connection with redemptions of our ordinary shares after or in connection with such initial business combination.
  • Risks Relating to the Post-Business Combination Company
  • Our ability to successfully effect a business combination and to be successful thereafter will be totally dependent upon the efforts of our key personnel, some of whom may join us following a business combination. While we intend to closely scrutinize any individuals we engage after a business combination, we cannot assure you that our assessment of these individuals will prove to be correct.
  • Our officers and directors may not have significant experience or knowledge regarding the jurisdiction or industry of the target business we may seek to acquire.
  • If we do not conduct an adequate due diligence investigation of a target business, we may be required to subsequently take write-downs or write-offs, restructuring, and impairment or other charges that could have a significant negative effect on our financial condition, results of operations and our share price, which could cause you to lose some or all of your investment.
  • If we effect a business combination with a company located in a foreign jurisdiction, we would be subject to a variety of additional risks that may negatively impact our operations.
  • If we effect a business combination with a company located outside of the United States, the laws applicable to such company will likely govern all of our material agreements and we may not be able to enforce our legal rights.
  • We may not be able to complete an initial business combination with a U.S. target company if such a transaction is subject to U.S. foreign investment regulations and review by a U.S. government entity such as CFIUS, or ultimately prohibited.
  • Because of the costs and difficulties inherent in managing cross-border business operations, our results of operations may be negatively impacted.
  • If social unrest, acts of terrorism, regime changes, changes in laws and regulations, political upheaval, or policy changes or enactments occur in a country in which we may operate after we effect our initial business combination, it may result in a negative impact on our business.
  • Many countries have difficult and unpredictable legal systems and underdeveloped laws and regulations that are unclear and subject to corruption and inexperience, which may adversely impact our results of operations and financial condition.
  • If we acquire a company operating in the infrastructure, E&C, industrial and renewables industries, our future operations may be subject to risks associated with this sector.
  • There may be tax consequences to our business combinations that may adversely affect us.
  • Risks Relating to Potential Conflicts of Interest of our Management, Directors, and Others
  • Our officers and directors will allocate their time to other businesses thereby causing conflicts of interest in their determination as to how much time to devote to our affairs. This could have a negative impact on our ability to consummate a business combination.
  • Our officers and directors may have a conflict of interest in determining whether a particular target business is appropriate for a business combination.
  • Our officers and directors or their affiliates have pre-existing fiduciary and contractual obligations and may in the future become affiliated with other entities engaged in business activities similar to those intended to be conducted by us. Accordingly, they may have conflicts of interest in determining to which entity a particular business opportunity should be presented.
  • Our key personnel may negotiate employment or consulting agreements with a target business in connection with a particular business combination. These agreements may provide for them to receive compensation following a business combination and as a result, may cause them to have conflicts of interest in determining whether a particular business combination is the most advantageous.
  • Risks Relating to our Securities
  • If we do not file and maintain a current and effective prospectus relating to the ordinary shares issuable upon exercise of the warrants, holders will only be able to exercise such warrants on a “cashless basis.”
  • An investor will only be able to exercise a warrant if the issuance of ordinary shares upon such exercise has been registered or qualified or is deemed exempt under the securities laws of the state of residence of the holder of the warrants.
  • We may amend the terms of the warrants in a manner that may be adverse to holders with the approval by the holders of at least a majority of the then outstanding warrants.
  • If third parties bring claims against us, the proceeds held in trust could be reduced and the per-share redemption price received by shareholders may be less than $10.00.
  • Our shareholders may be held liable for claims by third parties against us to the extent of distributions received by them.
  • Our directors may decide not to enforce Crescendo Advisors LLC’s indemnification obligations, resulting in a reduction in the amount of funds in the trust account available for distribution to our public shareholders.
  • The securities in which we invest the funds held in the trust account could bear a negative rate of interest, which could reduce the value of the assets held in trust such that the per-share redemption amount received by public shareholders may be less than $10.00 per share.
  • We may issue our shares to investors in connection with our initial business combination at a price that is less than the prevailing market price of our shares at that time.
  • The NYSE may delist our securities from quotation on its exchange which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions.
  • Our initial shareholders paid an aggregate of $25,000 for the founder shares, or approximately $0.005 per share. As a result, our initial shareholders stand to make a substantial profit even if an initial business combination subsequently declines in value or is unprofitable for our public shareholders, and may have an incentive to recommend such an initial business combination to our shareholders.
  • Our outstanding warrants may have an adverse effect on the market price of our ordinary shares and make it more difficult to effect a business combination.
  • We may redeem your unexpired warrants prior to their exercise at a time that is disadvantageous to you, thereby making your warrants worthless.
  • Our management’s ability to require holders of our warrants to exercise such warrants on a cashless basis will cause holders to receive fewer ordinary shares upon their exercise of the warrants than they would have received had they been able to exercise their warrants for cash.
  • If our security holders exercise their registration rights, it may have an adverse effect on the market price of our ordinary shares and the existence of these rights may make it more difficult to effect a business combination.
  • Provisions in our amended and restated memorandum and articles of association may inhibit a takeover of us, which could limit the price investors might be willing to pay in the future for our ordinary shares and could entrench management.
  • General Risks
  • Certain members of our management team have been, are now, or may in the future become, involved in litigation, investigations or other proceedings, including related to those companies or otherwise. The defense or prosecution of these matters could be time-consuming and could divert our management’s attention, and may have an adverse effect on us, which may impede our ability to consummate an initial business combination.
  • Unanticipated changes in our effective tax rate or challenges by tax authorities could harm our future results.
  • We may be a passive foreign investment company, or “PFIC,” which could result in adverse United States federal income tax consequences to U.S. investors.
  • We may de-register as a Cayman Islands exempted company and transfer by way of continuation to another jurisdiction in connection with our initial business combination and such transfer by way of continuation may result in taxes imposed on shareholders or warrant holders.
  • Because we are incorporated under the laws of the Cayman Islands, you may face difficulties in protecting your interests, and your ability to protect your rights through the U.S. federal courts may be limited.
  • Our amended and restated memorandum and articles of association provide that the courts of the Cayman Islands will be the exclusive forums for certain disputes between us and our shareholders, which could limit our shareholders’ ability to obtain a favorable judicial forum for complaints against us or our directors, officers or employees.
  • You may face difficulties in protecting your interests, and your ability to protect your rights through the U.S. Federal courts may be limited.
  • Changes in laws or regulations, or a failure to comply with any laws and regulations, may adversely affect our business, investments and results of operations.
  • We are an “emerging growth company” and “smaller reporting company” and we cannot be certain if the reduced disclosure requirements applicable to emerging growth companies and smaller reporting companies will make our ordinary shares less attractive to investors.
  • If we are deemed to be an investment company, we may be required to institute burdensome compliance requirements and our activities may be restricted, which may make it difficult for us to complete a business combination.
  • If we are deemed to be an investment company for purposes of the Investment Company Act, we could be forced to liquidate and investors in our company would not be able to participate in any benefits of owning stock in an operating business, including the potential appreciation of our stock following a business combination and our warrants would expire worthless.
  • Compliance with the Sarbanes-Oxley Act of 2002 will require substantial financial and management resources and may increase the time and costs of completing an acquisition.
  • Adverse developments affecting the financial services industry could adversely affect our liquidity, financial condition and results of operations, either directly or through adverse impacts on certain of our vendors and customers.

Legal proceedings

There is no material litigation, arbitration or governmental proceeding currently pending against us or any members of our management team in their capacity as such.

The opening of Item 3, Legal Proceedings.3

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30